Pages that link to "Q40219504"

The following pages link to Oncolytic HSV armed with platelet factor 4, an antiangiogenic agent, shows enhanced efficacy. (Q40219504):

Displaying 37 items.

• VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells (Q24618562) (← links)
• Oncolytic virus therapy: A new era of cancer treatment at dawn (Q26739714) (← links)
• Anti-angiogenic gene therapy in the treatment of malignant gliomas (Q26866276) (← links)
• Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates (Q27007519) (← links)
• Enhanced antitumor efficacy of vasculostatin (Vstat120) expressing oncolytic HSV-1. (Q33638847) (← links)
• Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primates (Q33720628) (← links)
• Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors (Q33794302) (← links)
• Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus. (Q33894449) (← links)
• Development of a regulatable oncolytic herpes simplex virus type 1 recombinant virus for tumor therapy (Q34046125) (← links)
• Expression of inhibitor of growth 4 by HSV1716 improves oncolytic potency and enhances efficacy (Q34275711) (← links)
• Current status of gene therapy for brain tumors. (Q34318157) (← links)
• Gene therapy progress and prospects cancer: oncolytic viruses. (Q34770611) (← links)
• Design and application of oncolytic HSV vectors for glioblastoma therapy (Q35559877) (← links)
• Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer. (Q35625500) (← links)
• ONCOLYTIC HERPES SIMPLEX VIRUS 1 (HSV-1) VECTORS: INCREASING TREATMENT EFFICACY AND RANGE THROUGH STRATEGIC VIRUS DESIGN. (Q35699072) (← links)
• Pediatric cancer gone viral. Part I: strategies for utilizing oncolytic herpes simplex virus-1 in children. (Q36109704) (← links)
• Designing Herpes Viruses as Oncolytics (Q36142487) (← links)
• Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors. (Q36849213) (← links)
• Targeting tumor vasculature through oncolytic virotherapy: recent advances (Q37031932) (← links)
• Advances in oncolytic virus therapy for glioma (Q37287118) (← links)
• Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors (Q37447217) (← links)
• Pharmacologic and chemical adjuvants in tumor virotherapy (Q37492540) (← links)
• "Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment (Q37622288) (← links)
• HSV Recombinant Vectors for Gene Therapy (Q37787777) (← links)
• Gene therapy and virotherapy: novel therapeutic approaches for brain tumors (Q37804933) (← links)
• Update on oncolytic viral therapy - targeting angiogenesis (Q38128561) (← links)
• Targeting Melanoma with Cancer-Killing Viruses (Q38676416) (← links)
• Oral squamous cell carcinoma patients can be differentiated from healthy individuals with label-free serum proteomics (Q38717277) (← links)
• Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models (Q39247534) (← links)
• Cellular effects of oncolytic viral therapy on the glioblastoma microenvironment (Q39787378) (← links)
• Enhanced antiglioma activity of chimeric HCMV/HSV-1 oncolytic viruses (Q40146542) (← links)
• Prospect and progress of oncolytic viruses for treating peripheral nerve sheath tumors. (Q40465319) (← links)
• Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses (Q41919532) (← links)
• Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects (Q41948724) (← links)
• Evaluation of the Safety and Biodistribution of M032, an Attenuated HSV-1 Virus Expressing hIL-12, After Intracerebral Administration to Aotus Non-Human Primates (Q42234691) (← links)
• "Armed" oncolytic herpes simplex viruses for brain tumor therapy (Q43189897) (← links)
• Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer (Q45360866) (← links)